Document Detail


Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study.
MedLine Citation:
PMID:  11953926     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: There is evidence that angiotensin II, the main effector of renin-angiotensin system, plays a crucial role in the pathogenesis of chronic renal injury. Angiotensin II type 1 (AT-1) receptor blockers reduce renin-angiotensin system activity by blocking the receptor, the activation of which is responsible for the majority of deleterious angiotensin II effects. The aim of the present study was to investigate renal and metabolic effects of specific AT-1 receptor blocker-losartan in patients with primary glomerulonephritis. DESIGN: Pilot clinical study. SETTING: Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Poland. PARTICIPANTS: Fifteen patients aged 43.3 +/- 11.3 years with primary glomerulonephritis confirmed by renal biopsy were studied. INTERVENTION: Creatinine clearance, urinary excretion of protein and uric acid, urinary activity of N-acetyl-beta-D-glucosaminidase, and serum concentrations of lipids, protein, and uric acid were evaluated before and after 3 months of losartan (Cozaar; Merck Sharp & Dohme, Harlow, Essex, United Kingdom) treatment at a dose of 25 mg daily. RESULTS: We found a significant reduction of urinary excretion of protein (P <.008; average, 32%). Results also revealed a decrease of serum uric acid level (P <.01), probably as a consequence of elevated uric acid urinary excretion (P <.09). No significant changes in creatinine clearance, N-acetyl-beta-D-glucosaminidase activity, protein, or lipid levels were observed. CONCLUSION: We concluded that losartan treatment at a small dose of 25 mg daily produces antiproteinuric effect without adverse effects, notably with no decrease of glomerular filtration, and simultaneously induces beneficial changes in purine metabolism.
Authors:
Leszek Tylicki; Marcin Renke; Przemyslaw Rutkowski; Boleslaw Rutkowski
Related Documents :
10401526 - Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smo...
12355566 - Fragmentation of uric acid calculi with the holmium: yag laser produces cyanide.
3051096 - Gouty arthritis in the adult.
11547986 - The effect of acid cleaning on a fine pore ceramic diffuser aeration system.
21049946 - Stabilization of alkylated azacrown ether by fatty acid at the air-water interface.
2630086 - Studies on the biosynthesis of corrinoids and porphyrinoids. i. the labeling of oxygen ...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation     Volume:  12     ISSN:  1051-2276     ISO Abbreviation:  J Ren Nutr     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-04-15     Completed Date:  2002-06-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9112938     Medline TA:  J Ren Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  122-5     Citation Subset:  IM    
Copyright Information:
Copyright 2002 by the National Kidney Foundation, Inc.
Affiliation:
Department of Nephrology, Transplantology and Internal Medicine, Medical University, Gdańsk, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Angiotensin II / antagonists & inhibitors*
Antihypertensive Agents / therapeutic use*,  urine
Female
Glomerulonephritis / drug therapy*,  urine
Humans
Losartan / therapeutic use*,  urine
Male
Middle Aged
Pilot Projects
Receptors, Angiotensin / antagonists & inhibitors*
Time Factors
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Receptors, Angiotensin; 11128-99-7/Angiotensin II; 114798-26-4/Losartan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anthropometric and growth assessment of children receiving renal replacement therapy in Malaysia.
Next Document:  Impact of a high-dependency care area on the nutritional management of patients with acute uremia.